Results of conservative management of epithelial malignant and borderline ovarian tumours

被引:73
作者
Morice, P
Camatte, S
Wicart-Poque, F
Atallah, D
Rouzier, R
Pautier, P
Pomel, C
Lhommé, C
Duvillard, P
Castaigne, D
机构
[1] Inst Gustave Roussy, Dept Gynecol Surg, Serv Chirurg Gynecol, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Dept Gynecol, F-94805 Villejuif, France
[3] Inst Gustave Roussy, Dept Pathol, F-94805 Villejuif, France
关键词
borderline tumour; conservative surgery; infertility treatment; ovarian cancer; pregnancy;
D O I
10.1093/humupd/dmg006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Conservative management of at least part of both the ovary and uterus can be proposed in patients with borderline ovarian tumour, in order to preserve fertility potential. This conservative management could be carried out even in patients with borderline ovarian tumour associated with non-invasive peritoneal implants (if complete resection of peritoneal disease has been performed). When facing persistent infertility after this conservative surgery, ovarian induction or an in-vitro procedure could be proposed in patients with an early-stage disease, though the number of attempts must be limited. Removal of the preserved ovary after completion of pregnancy(ies) is unnecessary if patients agree to careful follow-up. In patients with epithelial ovarian cancer, conservative management could safely be performed in young patients who wish to preserve fertility function and who fulfil the following criteria: unilateral tumour (stage IA), grade 1 (and 2?), adequate staging surgery and careful follow-up. Removal of the preserved ovary should be carried out after completion of pregnancy(ies) in order to reduce the risk of ovarian tumour recurrence.
引用
收藏
页码:185 / 192
页数:8
相关论文
共 83 条
[41]  
Leblanc E, 2000, SEMIN SURG ONCOL, V19, P36, DOI 10.1002/1098-2388(200007/08)19:1<36::AID-SSU6>3.0.CO
[42]  
2-E
[43]  
MADELENAT P, 1999, 10 C SOC FRANC ONC G
[44]   BORDERLINE EPITHELIAL OVARIAN-TUMORS - A REVIEW OF 81 CASES WITH AN ASSESSMENT OF THE IMPACT OF TREATMENT [J].
MANCHUL, LA ;
SIMM, J ;
LEVIN, W ;
FYLES, AW ;
DEMBO, AJ ;
PRINGLE, JF ;
RAWLINGS, GA ;
STURGEON, JFG ;
THOMAS, GM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 22 (05) :867-874
[45]   5 YEARS FOLLOW-UP IN 2 PATIENTS WITH BORDERLINE TUMORS OF THE OVARY HYPERSTIMULATED BY GONADOTROPIN THERAPY FOR IN-VITRO FERTILIZATION [J].
MANTZAVINOS, T ;
KANAKAS, N ;
GENATAS, C ;
PAPADIAS, K ;
ZOURLAS, PA .
HUMAN REPRODUCTION, 1994, 9 (11) :2032-2033
[46]  
Marchetti M, 1998, EUR J GYNAECOL ONCOL, V19, P297
[47]  
MASSAD LS, 1991, OBSTET GYNECOL, V78, P1027
[48]   Successful term pregnancy following conservative debulking surgery for a stage IIIA serous low-malignant-potential tumor of the ovary: A case report [J].
Miller, DM ;
Ehlen, TG ;
AlSaleh, E .
GYNECOLOGIC ONCOLOGY, 1997, 66 (03) :535-538
[49]   PRESERVATION OF OVARIAN-FUNCTION AND REPRODUCTIVE ABILITY IN PATIENTS WITH MALIGNANT OVARIAN-TUMORS [J].
MIYAZAKI, T ;
TOMODA, Y ;
OHTA, M ;
KANO, T ;
MIZUNO, K ;
SAKAKIBARA, K .
GYNECOLOGIC ONCOLOGY, 1988, 30 (03) :329-341
[50]   Long-term consequences following conservative management of epithelial ovarian cancer in an infertile patient [J].
Moore, MM ;
Tewari, K ;
Rose, GS ;
Fruehauf, JP ;
DiSaia, PJ .
GYNECOLOGIC ONCOLOGY, 1999, 73 (03) :452-454